Can we reduce clot risk without tipping the balance toward bleeding? A new ISTH Academy learning activity explores the growing potential of factor XI/XIa inhibitors in secondary stroke prevention and why these therapies are generating excitement: bit.ly/4uMFBQL

1 likes 0 replies